Financial statements Future Bio 9

Balance sheet of Future Bio 9

Company age:
Age:
12 y. 6 m. 7 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of FUTURE BIO 9

Year
2020
2021
2022
2023
Total assets 623 470,48 622 591,16 624 614,13 686 906,72
A. Fixed assets 493 688,60 493 688,60 493 688,60 542 469,09
B. Current assets 129 781,88 128 902,56 130 925,53 144 437,63
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00
Total liabilities 623 470,48 622 591,16 624 614,13 686 906,72
A. Equity -248 764,30 -274 349,29 -165 667,36 -230 451,09
B. Liabilities and provisions for liabilities 872 234,78 896 940,45 790 281,49 917 357,81
I. Long-term liabilities 0,00 0,00 0,00 0,00
II. Short-term liabilities 872 234,78 896 940,45 790 281,49 917 357,81
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.